1. Home
  2. MCHX vs XBIT Comparison

MCHX vs XBIT Comparison

Compare MCHX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

N/A

Current Price

$1.72

Market Cap

66.3M

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.51

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHX
XBIT
Founded
2003
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
75.0M
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
MCHX
XBIT
Price
$1.72
$2.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.6K
27.0K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,291,000.00
N/A
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$2.09
52 Week High
$2.30
$3.61

Technical Indicators

Market Signals
Indicator
MCHX
XBIT
Relative Strength Index (RSI) 65.15 66.40
Support Level $1.59 $2.15
Resistance Level $1.74 $2.69
Average True Range (ATR) 0.09 0.08
MACD 0.02 0.02
Stochastic Oscillator 94.92 81.25

Price Performance

Historical Comparison
MCHX
XBIT

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: